Siemens Aktiengesellschaft · XETR:SIE
Siemens Aktiengesellschaft — Siemens — Q3 FY2007 Earnings Presentation
15 slides from Siemens Aktiengesellschaft's earnings presentation, Jul 25, 2007
Slide 1: Accelerating growth and creating value
Accelerating growth and creating value Analyst Call July 25th, 2007 Peter Löscher, CEO Joe Kaeser, CFO
Slide 2: Safe Harbour Statement
Safe Harbour Statement This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified by words as “expects,” ”looks forward to,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will
Slide 3: Driving performance by further sharpening focus and building a strong portfolio
Driving performance by further sharpening focus and building a strong portfolio Portfolio People Excellence Build on our strengths in Energy & Develop talent globally Environmental Strengthen leadership Care development People Automation & Control, Attain high performance Portfolio Excel
Slide 4: Leading businesses in attractive application fields
Leading businesses in attractive application fields High quality of our businesses Os- PG PTD A&D I&S SBT TS SV MED SIS ram #1 or #2 position Attractive markets with tailwind from Application fields megatrends Increasing scarcity of Megatrends natural resources Energy & Environ- € 21 bn1) Growing ne
Slide 5: Sale of Siemens VDO to Continental creates significant shareholder value
Sale of Siemens VDO to Continental creates significant shareholder value • Straight sale of 100% of shares of Siemens VDO Automotive AG to Continental AG • Significant value upside compared to IPO Deal • Enterprise value of €11.4 bn (incl. €0.4 bn debt) structure • LTM1)-multiples EV/Sales: 1.1x, EV
Slide 6: Acquisition of Dade Behring to strengthen Siemens portfolio
Acquisition of Dade Behring to strengthen Siemens portfolio • Intention to submit a public take over bid over 100% of Dade Behring shares at Deal US$77 per share amounting to approx. 7 bn US$ or €5 bn structure • Expected closing Q2 FY 2008 (subject to receipt of regulatory approvals and other custo
Slide 7: Dade Behring is a unique opportunity to reach a #1 position in IVD
Dade Behring is a unique opportunity to reach a #1 position in IVD IVD1) Sales 2006 (in € bn) 3.3 3.2 1.4 2.3 1.9 1.5 1.4 1.1 1.9 0.9 0.3 Siemens & Roche Abbott Siemens Beckman Dade OCD (J&J) BioMerieux Olympus Dade Coulter Behring Behring 1) IVD: In vitro Diagnostics; Source: IVD Market model DX, 2
Slide 8: Building the first integrated diagnostics company worldwide
Building the first integrated diagnostics company worldwide #1 Workflow Oriented IT • Shared Medical (2000) Prevention, Diagnosis Early In Vivo Therapy Ongoing Care Detection In Vitro #1 #2 Diagnostics Diagnostics (IVD) (Imaging) •Bayer Diagnostics (2006) •CTI (2005) •Diagnostics Products Corporatio
Slide 9: Significant investment in portfolio and benefits to shareholders
Significant investment in portfolio and benefits to shareholders Capital bridge (in bn €)1) Cash items 11.4 2.7 • Value-creating sale of Siemens VDO to Continental 5.0 • Investments in portfolio: • Connecting the “Digital Factory” with the real manufacturing world (UGS) • Taking market leadership in
Slide 10: Outlook – Further portfolio strengthening for value creation
Outlook – Further portfolio strengthening for value creation Leading businesses in attractive markets High capital efficiency High quality of our businesses Top Groups high Os- PG PTD A&D I&S SBT TS SV MED SIS ram Profiteers #1 or #2 position CE RO ROCE** Attractive markets with tailwind from Applic
Slide 11: Key figures – third quarter of FY 2007
Key figures – third quarter of FY 2007 Key Financials – Q3 Q3 2007 Δ Q3 2006 (in millions of euros) (in millions of euros) New orders 22,147 +13% 19,656 (continuing operations) Revenue 20,176 +8% 18,689 (continuing operations) Group profit from Operations 1,504 +22% 1,231 (continuing operations) Inc
Slide 12: Reconciliation and Definitions for Non-GAAP Measures (I)
Reconciliation and Definitions for Non-GAAP Measures (I) Group profit from Operations is reconciled to Income before income taxes of Operations under Reconciliation to financial statements on the table Segment information. See our Financial Publications at our Investor Relations website under www.si
Slide 13: Reconciliation and Definitions for Non-GAAP Measures (II)
Reconciliation and Definitions for Non-GAAP Measures (II) Our cash target is based on the Cash Conversion Rate (CCR), which serves as a target indicator for the Company’s or the Group’s cash flow. For the Company, CCR is defined as the ratio of Free cash flow to Net income, where Free cash flow equa
Slide 14: Financial calendar
Financial calendar July 25 July Third quarter financial results FY07 – conference call November 8 Preliminary figures for FY07 November November 9 Annual analyst conference, Munich January 24 January Annual General Meeting, first quarter financial results FY08 – conference call Page 14 Q3 2007 Analy
Slide 15: Siemens Investor Relations Team
Siemens Investor Relations Team Marcus Desimoni +49-89-636-32445 Roland Bischofberger +49-89-636-36165 Florian Flossmann +49-89-636-34095 Irina Pchelova +49-89-636-33693 Christof Schwab +49-89-636-32677 Susanne Wölfinger +49-89-636-30639 Webpage: http://www.siemens.com/investorrelations e-mail: inve